Millie
your market intelligence analyst
Search Results
272 results
Your search is now limited to «Roche» expert search.
FDA approves Roche’s Tecentriq plus Cotellic and Zelboraf for people with advanced melanoma.
More from Pharmaceutical Business Review:
GlobeNewswire 08/03/2020 01:00
The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible.
More from GlobeNewswire:
ETHealthWorld (India) 07/31/2020 08:51
FDA nods for Roche’s Tecentriq plus Cotellic and Zelboraf for advanced melanoma, Health News, ET HealthWorld.
More from ETHealthWorld (India):
PharmiWeb.com 07/31/2020 08:30
Pune, Maharashtra, India, July 31 2020 (Wiredrelease) MarketResearch.Biz –: The recent report posted via MarketResearch.Biz on Molecular Weight Marker market offers critical market insights in conjunction with targeted segmentation evaluation. The report examines key using elements which might be anticipated to drive the increase of the market. Global Molecular Weight Marker Market Research Report offers crucial data on numerous market situations, for example, ability improvement elements, el...
More from PharmiWeb.com:
PMLiVE 07/31/2020 07:06
Roche has announced that the US Food and Drug Administration (FDA) has approved its PD-L1 inhibitor as a treatment for certain advanced melanoma patients.
More from PMLiVE:
MarketWatch 07/30/2020 11:15
Roche announced earlier this week that its rheumatoid arthritis drug Actemra failed in a late-stage clinical trial as a treatment for hospitalized COVID-19 patients.
More from MarketWatch:
Pharmafile 07/30/2020 06:07
UCB syncs up with Roche and Genentech in Alzheimer's drug deal worth a potential $2bn.
More from Pharmafile:
PR Newswire 07/30/2020 01:05
Other solutions from Roche for testing consolidation and connectivity in molecular laboratories include the cobas® 6800 and 8800 Systems, the cobas® infinity laboratory solution, and a broad and expanding menu of assays.
More from PR Newswire:
Seeking Alpha 07/29/2020 16:43
John Roche Thank you, Oksana.
More from Seeking Alpha:
Xconomy 07/29/2020 14:27
According to terms announced Wednesday, Roche is paying $120 million up front for global rights to the UCB drug, UCB0107.
More from Xconomy:

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors

Cells

Diagnostics and Therapeutics

Diseases

Drugs - Brand Names

Drugs - Generic

Enzymes

Genes

Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices

Proteins

Sources

Strategic Scenarios

Trends

Hints:

On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 


  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications